Opti Capital Management »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Opti Capital Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Opti Capital Management from 13F filings

Historical chart of Opti Capital Management investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Opti Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Opti Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $33M 36M 0.94

More positions owned by Opti Capital Management

Insight Enterprises Note 0.750% 2/1 (Principal)
Unity Software Note 11/1 (Principal)
Booking Holdings Note 0.750% 5/0 (Principal)
Fastly Note 3/1 (Principal)
Lumentum Hldgs Note 0.500%12/1 (Principal)
Novocure Note 11/0 (Principal)
Axon Enterprise Note 0.500%12/1 (Principal)
Five9 Note 0.500% 6/0 (Principal)
Infinera Corp Note 3.750% 8/0 (Principal)
Snap Note 5/0 (Principal)
Teladoc Health Note 1.250% 6/0 (Principal)
Nova Note 10/1 (Principal)
Nuvasive Note 0.375% 3/1 (Principal)
Rapid7 Note 0.250% 3/1 (Principal)
Dayforce Note 0.250% 3/1 (Principal)

View all positions for Opti Capital Management

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ing Investment Management
Deerfield Management Company
Aequim Alternative Investments
Lazard Asset Management
BlackRock
Davidson Kempner Capital Management
Invesco
Calamos Advisors
FMR
DeepCurrents Investment Group
State Street Corporation
Millennium Management
Wellington Management Company
MacKay Shields
Shenkman Capital Management

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1